15 completed, 2 unknown. 17 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 17 | Completed 15, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine Raltegravir/3TC, EFV/TDF/FTC, ATV/r + TDF/FTC or DRV/r + TDF/FTC - AIDS | Phase 3 | Completed | Juan A. Arnaiz | 75 | 2015-09-27 | 2025-07-20 |
| Test Albuvirtide in Experienced Patients albuvirtide, lopinavir-ritonavir, tenofovir - HIV Infections, AIDS | Phase 3 | Completed | Frontier Biotechnologies Inc. | 418 | 2014-02-19 | 2021-10-06 |
| Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients Maraviroc (Celsentri), Placebo - HIV-1 Infection, AIDS | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 407 | 2011-09-01 | 2016-07-12 |
| Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos Video or In-Person Presentation - HIV, AIDS | Phase 3 | Unknown | Rhode Island Hospital | 200 | 2011-08-01 | 2011-10-17 |
| Adherence, Improvement Measure (AIM) System SMS medication adherence, No SMS adherence reminder - Patient Compliance, AIDS | Phase 3 | Completed | University of California, San Francisco | 99 | 2010-08-01 | 2013-11-20 |
| Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru DOT-HAART - HIV, AIDS | Phase 3 | Completed | Brigham and Women's Hospital | 1244 | 2010-02-01 | 2017-10-25 |
| A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs) Positively Smoke Free, Standard care - Smoking, HIV Infections | Phase 3 | Completed | Montefiore Medical Center | 147 | 2009-12-01 | 2018-04-27 |
| Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) Nevirapine based therapy, Efavirenz based therapy, Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z) - Tuberculosis, Aids | Phase 2 / Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 570 | 2007-12-01 | 2012-02-15 |
| Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) Simplified follow-up approach of ARV treatment, Standard follow-up approach of ARV treatment - HIV Infections, AIDS | Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 459 | 2006-05-01 | 2016-07-22 |
| Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130) enfuvirtide, emtricitabine/tenofovir, lopinavir or efavirenz - HIV Infections, AIDS | Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 195 | 2006-04-01 | 2026-04-07 |
| Pediatric Nevirapine Resistance Study nevirapine - AIDS, HIV Infections | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 250 | 2005-04-01 | 2007-06-29 |
| Comparison of Facility and Home-based ART Delivery Systems in Uganda Antiretroviral therapy - AIDS | Phase 3 | Completed | Centers for Disease Control and Prevention | 1453 | 2005-02-01 | 2012-09-11 |
| Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission Carraguard (PC-515) - HIV Infections, AIDS | Phase 3 | Completed | Population Council | 6203 | 2004-04-01 | 2017-08-15 |
| Long Term Treatment Interruptions STI, stable HAART - HIV Infections, AIDS | Phase 3 | Completed | A.O. Ospedale Papa Giovanni XXIII | 320 | 2004-01-01 | 2008-04-25 |
| The Adult Antiretroviral Treatment and Resistance Study (Tshepo) (A) zidovudine, lamivudine and nevirapine, (B) zidovudine, lamivudine and efavirenz, (C) zidovudine, didanosine, and nevirapine - AIDS, HIV Infection | Phase 3 | Completed | Harvard School of Public Health (HSPH) | 650 | 2002-12-01 | 2012-09-17 |
| Phase III PEG-Intron in HIV-infected Patients (Study P00738) PEG-Intron - HIV Infections, AIDS | Phase 3 | Completed | Merck Sharp & Dohme LLC | 49 | 2002-03-01 | 2017-03-10 |
| Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) stavudine, efavirenz, lamivudine - HIV Infections, AIDS | Phase 3 | Completed | Bristol-Myers Squibb | 900 | 2001-01-01 | 2011-04-25 |
Acquired Immunodeficiency Syndrome (17) · HIV Infections (12) · Sexually Transmitted Diseases (2) · Coitus (1) · HIV Seropositivity (1) · Patient Compliance (1) · Safe Sex (1) · Sexual Behavior (1) · Smoking (1) · Tuberculosis (1)
Blood-Borne Infections (17) · Communicable Diseases (17) · Genital Diseases (17) · Immune System Diseases (17) · Immunologic Deficiency Syndromes (17) · Infections (17) · Lentivirus Infections (17) · RNA Virus Infections (17) · Retroviridae Infections (17) · Sexually Transmitted Diseases, Viral (17) · Slow Virus Diseases (17) · Urogenital Diseases (17) · Virus Diseases (17) · Sexually Transmitted Diseases (15) · HIV Infections (5)
efavirenz (4) · Lamivudine (3) · Lopinavir (2) · Nevirapine (2) · Stavudine (2) · lopinavir-ritonavir drug combination (2) · Antiretroviral Therapy, Highly Active (1) · Didanosine (1) · Dosage Forms (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Enfuvirtide (1) · Ethambutol (1) · Fumigant 93 (1) · Isoniazid (1) · Maraviroc (1)
French National Agency for Research on AIDS and Viral Hepatitis (3) · A.O. Ospedale Papa Giovanni XXIII (1) · ANRS, Emerging Infectious Diseases (1) · Brigham and Women's Hospital (1) · Bristol-Myers Squibb (1) · Centers for Disease Control and Prevention (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Frontier Biotechnologies Inc. (1) · Harvard School of Public Health (HSPH) (1) · Juan A. Arnaiz (1) · Merck Sharp & Dohme LLC (1) · Montefiore Medical Center (1) · Population Council (1) · Rhode Island Hospital (1) · University of California, San Francisco (1)
United States (4) · France (3) · South Africa (3) · Italy (2) · Spain (2) · Argentina (1) · Belgium (1) · Botswana (1) · Brazil (1) · Cameroon (1) · Canada (1) · China (1) · Israel (1) · Mexico (1) · Mozambique (1)
Alex Coutinho, MBChB, MSc (1) · Charles Kouandack (1) · Christian Laurent (1) · Dominique Costagliola, PhD (1) · Dong Xie (1) · Dr. Roland Merchant, MD, MPH, ScD (1) · Eric Delaporte (1) · Esteban Martinez, MD PhD (1) · Franco Maggiolo, MD (1) · Heiner Grosskurth, MD, PhD (1) · James Kahn, MD (1) · Jean-Daniel Lelievre, MD, PhD (1) · Jonathan Shuter, MD (1) · Louise Kuhn, Ph.D. (1)
PMID 19059048, PMID 20823434, PMID 21831714, PMID 22424722, PMID 22732470, PMID 23165467, PMID 23433590, PMID 24521425, PMID 24663014, PMID 25179540, PMID 27215559, PMID 27546069, PMID 32040959, PMID 33252379, PMID 35248123
1RC1MH088341 (1), 2005 (1), 2014 (1), R01MH083550 (1), U01PS000065 (1)